Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Budesonide refill 100dose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
Budesonide refill 200dose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
budesonid 50 µg inhalator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
Fluticasone propionate [respiratory use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
fluticasonpropionat 50 µg blisterplader + diskhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
fluticasonpropionat 100 µg blisterplader + diskhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
fluticasonpropionat 250 µg blisterplader + diskhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
fluticasonpropionat 50 µg blisterplader til genopfyldning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
fluticasonpropionat 100 µg blisterplader til genopfyldning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
fluticasonpropionat 250 µg blisterplader til genopfyldning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
fluticasonpropionat 25 µg inhalator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
fluticasonpropionat 50 µg inhalator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
fluticasonpropionat 125 µg inhalator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
fluticasonpropionat 250 µg inhalator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
fluticasonpropionat 500 µg blisterplader + diskhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
fluticasonpropionat 500 µg blisterplader til genopfyldning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
fluticasonpropionat 50 µg indåndingsudløst tørpulverinhalator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
fluticasonpropionat 100 µg indåndingsudløst tørpulverinhalator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
fluticasonpropionat 250 µg indåndingsudløst tørpulverinhalator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
fluticasonpropionat 500 µg indåndingsudløst tørpulverinhalator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
fluticasonpropionat 0,5 mg/2 ml nebulisatorampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
fluticasonpropionat 2 mg/2 ml nebulisatorampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
fluticasonpropionat 125 µg CFC-fri inhalator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
fluticasonpropionat 250 µg CFC-fri inhalator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
fluticasonpropionat 50 µg CFC-fri inhalator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
Beclomethasone dipropionate [respiratory use 2] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
beclometasondipropionat 50 µg indåndingsudløst tørpulverinhalator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
beclometasondipropionat 100 µg indåndingsudløst tørpulverinhalator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
beclometasondipropionat 250 µg indåndingsudløst tørpulverinhalator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
beclometasondipropionatpræparat opløsning til nasal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
Product containing precisely fludrocortisone acetate 100 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
Deoxycortone pivalate [no preparations] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
betamethason 500 µg opløselig tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
Betamethasone 500 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
betamethason 4 mg/ml injektionsvæske, opløsning, ampul a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
Hydrocortisone 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
Hydrocortisone 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
Methylprednisolone [endocrine use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
methylprednisolonacetat 80 mg/2 ml+ lidocainhydrochlorid 20 mg/2 ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
methylprednisolonacetat 40/1 ml + lidocainhydrochlorid 10 mg/1 ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
methylprednisolonacetat 40 mg/ml injektionsvæske, suspension, hætteglas a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
methylprednisolon 50 mg/ml injektionsvæske, opløsning, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
methylprednisolon 50 mg/ml injektionsvæske, opløsning, hætteglas a 20 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
methylprednisolon 500 mg pulver til injektionsvæske, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
methylprednisolon 1 g pulver til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
Methylprednisolone 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
Methylprednisolone 2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
Methylprednisolone 4 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
Methylprednisolone 16 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
methylprednisolon 40 mg pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
methylprednisolon 125 mg pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
methylprednisolon 500 mg pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
methylprednisolon 1 g pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
methylprednisolon 2 g pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
methylprednisolonacetat 40 mg/ml injektionsvæske, suspension, hætteglas a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
methylprednisolonacetat 40 mg/ml injektionsvæske, suspension, hætteglas a 2 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
Prednisone 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
Triamcinolone [endocrine use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
Kenalog 80mg/2mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
triamcinolonacetonid 40 mg/ml injektionsvæske, suspension i fyldt injektionssprøjte a 2 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
triamcinolonacetonid 40 mg/ml injektionsvæske, suspension i fyldt injektionssprøjte a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
Triamcinolone 40mg/1mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
Triamcinolone 80mg/2mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
Deflazacort 6 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
Deflazacort 30 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
Deflazacort 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
Systemic steroids + acth |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
Local corticosteroid injections |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
Methylprednisolone acetate [musculoskeletal use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
Triamcinolone acetonide [musculoskeletal use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
triamcinolonacetonid 10 mg/ml injektionsvæske, suspension, ampul a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
triamcinolonacetonid 10 mg/ml injektionsvæske, suspension, hætteglas a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
triamcinolonacetonid 40 mg/1 ml injektionsvæske til intraartikulær/intramuskulær anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
triamcinolonhexacetonid 5 mg/ml injektionsvæske, opløsning, hætteglas a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
Corticoster + anti-infl [eye] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
Betamethasone sodium phosphate [eye] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
Betamethasone sodium phosphate 1 mg/g eye ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
Clobetasone butyrate [eye] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
Clobetasone butyrate 1 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
Fluorometholone 1 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
Betamethasone sodium phosphate [ear] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
Product containing precisely neomycin 3.5 milligram/1 milliliter and triamcinolone acetonide 1 milligram/1 milliliter conventional release ear drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
Beclomethasone dipropionate [nose] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
beclometasondipropionat 50 µg vandig næsespray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
Betamethasone sodium phosphate [nose] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
Budesonide [nose] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
budesonid 100 µg vandig næsespray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
Fluticasone [nose] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
fluticasonpropionat 50 µg vandig næsespray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
fluticasonpropionat 400 µg næsedråber til engangsbrug |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
Triamcinolone acetate [nose] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
triamcinolonacetonid 55 µg vandig næsespray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
Mometasone furoate monohydrate [nose] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
mometasonfuroatmonohydrat 0,05 % vandig næsespray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
Corticosteroids for oropharynx |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
Triamcinolone acetonide 1 mg/g oromucosal paste |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
Hydrocortisone (as hydrocortisone sodium succinate) 2.5 mg oromucosal lozenge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
kortikosteroider til topikal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|
hydrocortison cremer |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone |
Inferred relationship |
Some |
|